Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Entasis 3D Dual-Lead Sacroiliac Implant System

K-Number: K223708 · 2023-03-21

ApplicantCorelink, LLC
Decision Date2023-03-21
Product CodeOUR
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

Entasis 3D Dual-Lead Sacroiliac Implant System is a medical device manufactured by Corelink, LLC. It received FDA 510(k) clearance on 2023-03-21 under approval number K223708. The device is classified under product code OUR. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Entasis 3D Dual-Lead Sacroiliac Implant System?

Entasis 3D Dual-Lead Sacroiliac Implant System is a medical device that received FDA 510(k) clearance on 2023-03-21. It is manufactured by Corelink, LLC. The 510(k) number is K223708.

When was Entasis 3D Dual-Lead Sacroiliac Implant System approved by the FDA?

Entasis 3D Dual-Lead Sacroiliac Implant System received FDA 510(k) clearance on 2023-03-21, under approval number K223708.

What company makes Entasis 3D Dual-Lead Sacroiliac Implant System?

Entasis 3D Dual-Lead Sacroiliac Implant System is manufactured by Corelink, LLC.

What is the FDA product code for Entasis 3D Dual-Lead Sacroiliac Implant System?

The FDA product code for Entasis 3D Dual-Lead Sacroiliac Implant System is OUR.

Related Clinical Trials

Related PubMed Literature

Other Devices by Corelink, LLC

View all 23 devices →

Related Devices (Code: OUR)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.